-
1
-
-
0031974383
-
Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide
-
Harenberg J. Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide. Med Res Rev. 1998 ; 18: 1-20.
-
(1998)
Med Res Rev
, vol.18
, pp. 1-20
-
-
Harenberg, J.1
-
2
-
-
0031938089
-
Pharmacological actions of sulodexide
-
Ofosu FA Pharmacological actions of sulodexide. Semin Thromb Hemost. 1998 ; 24: 127-138.
-
(1998)
Semin Thromb Hemost
, vol.24
, pp. 127-138
-
-
Ofosu, F.A.1
-
3
-
-
33746691250
-
The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy
-
Abaterusso C., Gambaro G. The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. Treat Endocrinol. 2006 ; 5: 211-222.
-
(2006)
Treat Endocrinol
, vol.5
, pp. 211-222
-
-
Abaterusso, C.1
Gambaro, G.2
-
4
-
-
33847767217
-
Sulodexide: A renewed interest in this glycosaminoglycan
-
Lauver DA, Lucchesi BR Sulodexide: a renewed interest in this glycosaminoglycan. Cardiovasc Drug Rev. 2006 ; 24: 214-226.
-
(2006)
Cardiovasc Drug Rev
, vol.24
, pp. 214-226
-
-
Lauver, D.A.1
Lucchesi, B.R.2
-
6
-
-
58449135502
-
Pleiotropic effects of heparin and heparinoids in peritoneal dialysis
-
2009
-
Gozdzikiewicz J., Borawski J., Mysliwiec M. Pleiotropic effects of heparin and heparinoids in peritoneal dialysis. Clin Appl Thromb Hemost. 2009. doi:10.1177/ 1076029607304722. Already published 2009 ; 15: 92-97.
-
(2009)
Clin Appl Thromb Hemost
, vol.15
, pp. 92-97
-
-
Gozdzikiewicz, J.1
Borawski, J.2
Mysliwiec, M.3
-
7
-
-
76049101885
-
Effect of sulodexide on plasma transforming growth factor-beta1 in healthy volunteers
-
Borawski J., Dubowski M., Pawlak K., Mysliwiec M. Effect of sulodexide on plasma transforming growth factor-beta1 in healthy volunteers. Clin Appl Thromb Hemost. 2008 doi:10.1177/1076029608326170.
-
(2008)
Clin Appl Thromb Hemost
-
-
Borawski, J.1
Dubowski, M.2
Pawlak, K.3
Mysliwiec, M.4
-
8
-
-
0028641215
-
Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo
-
Eichinger S., Wolz M., Nieszpaur-Los M., et al. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo. Thromb Haemost. 1994 ; 72: 831-835.
-
(1994)
Thromb Haemost
, vol.72
, pp. 831-835
-
-
Eichinger, S.1
Wolz, M.2
Nieszpaur-Los, M.3
-
9
-
-
0026643206
-
Influence of heparin treatment on biochemical markers of an activation of the coagulation system
-
Amelsberg A., Zurborn KH, Gartner U., Kiehne KH, Preusse AK, Bruhn HD Influence of heparin treatment on biochemical markers of an activation of the coagulation system. Thromb Res. 1992 ; 66: 121-131.
-
(1992)
Thromb Res
, vol.66
, pp. 121-131
-
-
Amelsberg, A.1
Zurborn, K.H.2
Gartner, U.3
Kiehne, K.H.4
Preusse, A.K.5
Bruhn, H.D.6
-
10
-
-
43249130447
-
Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II
-
He L., Giri TK, Vicente CP, Tollefsen DM Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II. Blood. 2008 ; 111: 4118-4125.
-
(2008)
Blood
, vol.111
, pp. 4118-4125
-
-
He, L.1
Giri, T.K.2
Vicente, C.P.3
Tollefsen, D.M.4
-
11
-
-
0035805579
-
Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin
-
Chuang YJ, Swanson R., Raja SM, Olson ST Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin. J Biol Chem. 2001 ; 276: 14961-14967.
-
(2001)
J Biol Chem
, vol.276
, pp. 14961-14967
-
-
Chuang, Y.J.1
Swanson, R.2
Raja, S.M.3
Olson, S.T.4
-
12
-
-
33746704346
-
Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndrome
-
van der Putten RFM, Glatz JFC, Hermens WT Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndrome. Clin Chim Acta. 2006 ; 371: 37-54.
-
(2006)
Clin Chim Acta
, vol.371
, pp. 37-54
-
-
Van Der Putten, R.F.M.1
Glatz, J.F.C.2
Hermens, W.T.3
-
13
-
-
0027414751
-
Prothrombin fragment F1+2 concentrations for monitoring anticoagulation therapy with heparin
-
Brack MJ, More RS, Hubner PJ, Gershlick AH Prothrombin fragment F1+2 concentrations for monitoring anticoagulation therapy with heparin. Int J Cardiol. 1993 ; 38: 57.
-
(1993)
Int J Cardiol
, vol.38
, pp. 57
-
-
Brack, M.J.1
More, R.S.2
Hubner, P.J.3
Gershlick, A.H.4
-
14
-
-
0030995765
-
Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators
-
Feinberg WM, Cornell ES, Nightingale SD, et al. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Stroke. 1997 ; 28: 1101-1106.
-
(1997)
Stroke
, vol.28
, pp. 1101-1106
-
-
Feinberg, W.M.1
Cornell, E.S.2
Nightingale, S.D.3
-
15
-
-
0025834924
-
Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities
-
Linhardt RJ, al- Hakim A., Liu JA, et al. Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities. Biochem Pharmacol. 1991 ; 42: 1609-1619.
-
(1991)
Biochem Pharmacol
, vol.42
, pp. 1609-1619
-
-
Linhardt, R.J.1
Hakim, A.2
Liu, J.A.3
-
16
-
-
0035877794
-
Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin
-
Liaw PC, Becker DL, Stafford AR, Fredenburgh JC, Weitz JI Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin. J Biol Chem. 2001 ; 276: 20959-20965.
-
(2001)
J Biol Chem
, vol.276
, pp. 20959-20965
-
-
Liaw, P.C.1
Becker, D.L.2
Stafford, A.R.3
Fredenburgh, J.C.4
Weitz, J.I.5
|